Compile Data Set for Download or QSAR
Report error Found 213 Enz. Inhib. hit(s) with all data for entry = 12956
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744528(US20250170126, Compound I-96)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744586(US20250170126, Compound I-186)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744469(US20250170126, Compound I-36)
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744596(US20250170126, Compound I-196)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744524(US20250170126, Compound I-92)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744580(US20250170126, Compound I-180)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744467(US20250170126, Compound I-34)
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744590(US20250170126, Compound I-190)
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744648(US20250170126, Compound I-281)
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744602(US20250170126, Compound I-202)
Affinity DataIC50: 22nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744519(US20250170126, Compound I-86)
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744522(US20250170126, Compound I-90)
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744443(US20250170126, Compound I-6)
Affinity DataIC50: 24nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744478(US20250170126, Compound I-45)
Affinity DataIC50: 24nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744628(US20250170126, Compound I-260)
Affinity DataIC50: 24nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744597(US20250170126, Compound I-197)
Affinity DataIC50: 25nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744587(US20250170126, Compound I-187)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744649(US20250170126, Compound I-282)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744472(US20250170126, Compound I-39)
Affinity DataIC50: 29nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744473(US20250170126, Compound I-40)
Affinity DataIC50: 29nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744547(US20250170126, Compound I-119)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744573(US20250170126, Compound I-173)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744592(US20250170126, Compound I-192)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744525(US20250170126, Compound I-93)
Affinity DataIC50: 31nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744533(US20250170126, Compound I-103)
Affinity DataIC50: 31nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744585(US20250170126, Compound I-185)
Affinity DataIC50: 31nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744591(US20250170126, Compound I-191)
Affinity DataIC50: 31nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744601(US20250170126, Compound I-201)
Affinity DataIC50: 32nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744609(US20250170126, Compound I-209)
Affinity DataIC50: 32nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744622(US20250170126, Compound I-222)
Affinity DataIC50: 33nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744588(US20250170126, Compound I-188)
Affinity DataIC50: 34nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744627(US20250170126, Compound I-236)
Affinity DataIC50: 34nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744589(US20250170126, Compound I-189)
Affinity DataIC50: 35nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744523(US20250170126, Compound I-91)
Affinity DataIC50: 36nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744552(US20250170126, Compound I-126)
Affinity DataIC50: 38nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744527(US20250170126, Compound I-95)
Affinity DataIC50: 39nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744544(US20250170126, Compound I-116)
Affinity DataIC50: 39nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744440(US20250170126, Compound I-3)
Affinity DataIC50: 40nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744526(US20250170126, Compound I-94)
Affinity DataIC50: 40nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744600(US20250170126, Compound I-200)
Affinity DataIC50: 41nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744623(US20250170126, Compound I-223)
Affinity DataIC50: 41nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744513(US20250170126, Compound I-80)
Affinity DataIC50: 42nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744612(US20250170126, Compound I-212)
Affinity DataIC50: 43nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744620(US20250170126, Compound I-220)
Affinity DataIC50: 43nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744572(US20250170126, Compound I-172)
Affinity DataIC50: 44nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744621(US20250170126, Compound I-221)
Affinity DataIC50: 44nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744624(US20250170126, Compound I-224)
Affinity DataIC50: 44nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744625(US20250170126, Compound I-225)
Affinity DataIC50: 44nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744603(US20250170126, Compound I-203)
Affinity DataIC50: 45nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma

US Patent
LigandPNGBDBM744471(US20250170126, Compound I-38)
Affinity DataIC50: 46nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/23/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 213 total ) | Next | Last >>
Jump to: